Get in Touch

This site is intended for UK healthcare professionals only and contains promotional information.UK Flag Please visit the MHRA Yellowcard site to report an Adverse Event.

Home/Therapy areas/Diabetes and Endocrinology/Why Choose Invokana

Why choose INVOKANA® (canagliflozin)?

Prescribing Information can be found under Useful Links

 

Invokana®(canagliflozin) is indicated for the treatment of adults with insufficiently controlled type 2 diabetes mellitus as an adjunct to diet and exercise:

  • As monotherapy when metformin is considered inappropriate due to intolerance or contraindications
  • In addition to other medicinal products for the treatment of diabetes

For study results with respect to combination of therapies, effects on glycaemic control, cardiovascular and renal events, and the populations studied, please refer to section 4.4, 4.5 and 5.1 of the Invokana SmPC.

When managing your patients with type 2 diabetes (T2D) there are lots of factors you need to consider, like managing their blood glucose levels, HbA1c, protecting their kidney function and protecting against cardiovascular disease.

NICE Guidelines recommend the use of SGLT-2 inhibitors such as Invokana, with proven cardiovascular benefits, to improve cardiovascular outcomes in patients with type 2 diabetes.1

Invokana indication638248610146054750

Invokana-Elipse-1

Invokana-Elipse-2

Invokana-Elipse-3

Invokana-Arrow-2

PP-IN-UK-0196 July 2023

Adverse events should be reported. Reporting forms and information can be found at www.yellowcard.mhra.gov.uk or search for MHRA Yellow Card in Google Play or Apple App Store.

Adverse events should also be reported to A. Menarini Farmaceutica Internazionale SRL.

Phone 0800 085 8678

Useful Links Edit Cookies Settings
Contact Us Get in Touch

This site is intended only for healthcare professionals resident in the United Kingdom. If you are a member of the public wishing to access information on a specific medicine, please visit www.medicines.org.uk/emc.

 

This website is brought to you by A. Menarini Farmaceutica Internazionale SRL, a company registered in England and Wales under No. BR016024 with its registered office at Menarini House, Mercury Park, Wycombe Lane, Wooburn Green, High Wycombe, HP10 0HH.

Copyright © 2021 Menarini. All rights reserved. VAT number 143099806. PP-MN-UK-0549 May 2024